Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: NOSODE: Nosode in current methodology
to develop a protective medicine
to help patient infected with
newly emerged virusCovid-19.
In Homeopathy method, using
various plants, metals or s
Sponsors
CENTRAL COUNCIL FOR RESEARCH IN HOMEOPATHY Ministry of AYUSH
Eligibility
Inclusion criteria
Inclusion criteria: Hospitalized patients with confirmed COVID-19 infection Age between 18 years to 80 years of both gender Willing to give signed written informed consent
Exclusion criteria
Exclusion criteria: Patients on ventilator support Immuno-compromised patients Severe heart, lung, kidney, brain, blood diseases or other important systemic diseases Subjects considered to be unable to complete the study, or not suitable for the study by researchers. Women during pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the safety, effects and feasibility of the prepared Nosodes and â??Control Nosodeâ?? with different potency (6, 30, 200 etc) in treatment of Covid-19 in animal model. To study and determine safe dose in healthy individuals in Phase.Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the therapeutic efficacy of these Nosodes in symptomatic patients warranting treatment (Therapeutic doses will be given to these patients) in Phase II To study the mechanism of action of Nosodes in treatment of COVID-19 by studying cytokines. To evaluate the probability of using Nosode as prophylactic in high risk individuals (eg. Individuals in contact with Covid-19 infected patients). Phase 3 use of Nosode as preventive strategy piloted in selected regions.Timepoint: 6 MONTHS | — |
Countries
India
Contacts
Public ContactDr Naval Kumar Verma
Central Council for Research in Homoeopathy (CCRH)
Outcome results
None listed